Dengfeng Cheng - Search Results

Year	Number of Results
2006	1
2007	2
2008	2
2009	5
2010	7
2011	9
2012	4
2013	7
2014	4
2015	7
2016	14
2017	8
2018	6
2019	11
2020	9
2021	6
2022	11
2023	7
2024	4

1

Fluorine-18: Radiochemistry and Target-Specific PET Molecular Probes Design.

Wang Y, Lin Q, Shi H, Cheng D. Wang Y, et al. Among authors: cheng d. Front Chem. 2022 Jun 29;10:884517. doi: 10.3389/fchem.2022.884517. eCollection 2022. Front Chem. 2022. PMID: 35844642 Free PMC article. Review.

2

Using magnetoferritin nanoprobes for both nuclear and magnetic-resonance imaging.

Tan H, Cheng D. Tan H, et al. Among authors: cheng d. Nanomedicine (Lond). 2017 Jan;12(1):9-11. doi: 10.2217/nnm-2016-0369. Epub 2016 Nov 23. Nanomedicine (Lond). 2017. PMID: 27876442 Review. No abstract available.

3

¹²⁴I-Labeled Immuno-PET Targeting hTREM2 for the Diagnosis of Gastric Carcinoma.

Shi D, Xu Z, Cheng Y, Lin Q, Si Z, Fu W, Yang T, Shi H, Cheng D. Shi D, et al. Among authors: cheng d. Mol Pharm. 2023 Apr 3;20(4):2235-2244. doi: 10.1021/acs.molpharmaceut.3c00041. Epub 2023 Mar 23. Mol Pharm. 2023. PMID: 36951296

4

Application of New Molecular Probes in the Diagnosis and Treatment of Malignant Tumors.

Cheng D, Lu H. Cheng D, et al. Cancers (Basel). 2023 Sep 27;15(19):4752. doi: 10.3390/cancers15194752. Cancers (Basel). 2023. PMID: 37835446 Free PMC article.

5

Cargo loading within ferritin nanocages in preparation for tumor-targeted delivery.

Zhang J, Cheng D, He J, Hong J, Yuan C, Liang M. Zhang J, et al. Among authors: cheng d. Nat Protoc. 2021 Oct;16(10):4878-4896. doi: 10.1038/s41596-021-00602-5. Epub 2021 Sep 8. Nat Protoc. 2021. PMID: 34497386 Review.

6

Separate luminous structures leading positive leader steps.

Huang S, Chen W, Fu Z, Fu Y, Xiang N, Qiu X, Shi W, Cheng D, Zhang Z. Huang S, et al. Among authors: cheng d. Nat Commun. 2022 Jun 27;13(1):3655. doi: 10.1038/s41467-022-31409-x. Nat Commun. 2022. PMID: 35760811 Free PMC article.

7

Assessing antibody pharmacokinetics in mice with in vivo imaging.

Hoppin J, Orcutt KD, Hesterman JY, Silva MD, Cheng D, Lackas C, Rusckowski M. Hoppin J, et al. Among authors: cheng d. J Pharmacol Exp Ther. 2011 May;337(2):350-8. doi: 10.1124/jpet.110.172916. Epub 2011 Feb 11. J Pharmacol Exp Ther. 2011. PMID: 21317355 Review.

8

The incremental clinical value of cardiac hybrid SPECT/CTA imaging in coronary artery disease.

Qiu L, Tan H, Cheng D, Shi H. Qiu L, et al. Among authors: cheng d. Nucl Med Commun. 2018 Jun;39(6):469-478. doi: 10.1097/MNM.0000000000000838. Nucl Med Commun. 2018. PMID: 29652747 Review.

9

Noninvasive evaluation of PD-L1 expression in non-small cell lung cancer by immunoPET imaging using an acylating agent-modified antibody fragment.

Cheng Y, Shi D, Ye R, Fu W, Ma P, Si Z, Xu Z, Li L, Lin Q, Cheng D. Cheng Y, et al. Among authors: cheng d. Eur J Nucl Med Mol Imaging. 2023 May;50(6):1585-1596. doi: 10.1007/s00259-023-06130-6. Epub 2023 Feb 10. Eur J Nucl Med Mol Imaging. 2023. PMID: 36759371

10

Pretargeted Nuclear Imaging and Radioimmunotherapy Based on the Inverse Electron-Demand Diels-Alder Reaction and Key Factors in the Pretargeted Synthetic Design.

Qiu L, Mao W, Yin H, Tan H, Cheng D, Shi H. Qiu L, et al. Among authors: cheng d. Contrast Media Mol Imaging. 2019 Aug 25;2019:9182476. doi: 10.1155/2019/9182476. eCollection 2019. Contrast Media Mol Imaging. 2019. PMID: 31531006 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

110 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

110 results

Results by year